
    
      Primary Aim: To conduct a dose response pilot trial of low (30 min/day) or high (60 min/day)
      dose exercise in men and women at increased risk of colon cancer. The major outcomes are
      changes in serum levels of four risk-related biomarkers: insulin, C-peptide, IL-6 and PGE-2.

      Secondary Aim. To compare changes in the secondary outcome of physical activity over three
      months.
    
  